A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
J Clin Psychiatry
; 70(4): 487-99, 2009 Apr.
Article
en En
| MEDLINE
| ID: mdl-19358783
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Esquizofrenia
/
Antipsicóticos
/
Benzodiazepinas
/
Risperidona
/
Dibenzotiazepinas
/
Glucosa
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Idioma:
En
Revista:
J Clin Psychiatry
Año:
2009
Tipo del documento:
Article